Immune tolerance elicited via unique ocular and oral routes

Current Molecular Medicine

Volumn 15, Issue 1, 2015, Pages 78-81

  Ashour, H M ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

ACAID; Cytokines; Nickel; Oral tolerance; T regulatory cells; Tolerance

Indexed keywords

ALLERGEN; COMPLEMENT FIXING ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; NICKEL;

ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION; ANTERIOR EYE CHAMBER; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DOWN REGULATION; GAMMA DELTA T LYMPHOCYTE; HYPERSENSITIVITY CONCEPTS; IMMUNOLOGICAL TOLERANCE; NATURAL KILLER T CELL; NICKEL INDUCED ORAL TOLERANCE; NONHUMAN; REGULATORY T LYMPHOCYTE; UPREGULATION; ANIMAL; DRUG EFFECTS; EYE; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY;

ANIMALS; ANTERIOR CHAMBER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EYE; HUMANS; IMMUNE TOLERANCE; MICE; NICKEL; T-LYMPHOCYTES, REGULATORY;

EID: 84922335789     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150114114602     Document Type: Article

References (53)

1. Farooq SM, Ashour HM. Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells. PLoS One 2012; 7(11): e48635.
2. Farooq SM, Ashour HM. The in vitro induction of type II collagen-specific immune tolerance in BALB/c mice. Eur J Inflamm 2013; 11(1): 169-78.
3. Farooq SM, Ashour HM. Eye-mediated induction of specific immune tolerance to encephalitogenic antigens. CNS Neurosci Ther 2013; 19(7): 503-10.
4. Farooq SM, Ashour HM. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens. Brain Behav Immun 2014; 35: 64-9.
5. Streilein JW. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol 1990; 35(1): 67-73.
6. Wilbanks GA, Streilein JW. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 1990; 71(4): 566-72.
7. D'Orazio TJ, Niederkorn JY. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 1998; 160(5): 2089-98.
8. Wilbanks GA, Streilein JW. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol 1992; 4(3): 130-7.
9. D'Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998; 95(1): 47-55.
10. Nakamura T, Sonoda KH, Faunce DE, et al. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 2003; 171(3): 1266-71.
11. Skelsey ME, Mayhew E, Niederkorn JY. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 2003; 44(12): 5242-51.
12. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immuneprivileged site. J Exp Med 1999; 190(9): 1215-26.
13. Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001; 166(1): 42-50.
14. Ashour HM, Seif TM. The role of B cells in the induction of peripheral T cell tolerance. J Leukoc Biol 2007; 82(5): 1033-9.
15. Jiang L, He H, Yang P, et al. Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation. Graefes Arch Clin Exp Ophthalmol 2009; 247(1): 87-92.
16. Ashour HM, Niederkorn JY. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J Immunol 2006; 177(12): 8331-7.
17. Ji SX, Yin XL, Yang PZ. Effect of CD4(+)CD25(+) regulatory T cells in the development of anterior chamber-associated immune deviation. Int J Ophthalmol 2011; 4(1): 19-25.
18. Skelsey ME, Mayhew E, Niederkorn JY. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003; 110(1): 18-29.
19. Tsukahara R, Takeuchi M, Akiba H, et al. Critical contribution of CD80 and CD86 to induction of anterior chamberassociated immune deviation. Int Immunol, 17(5), 523-30.
20. Ashour HM, Niederkorn JY. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J Immunol 2006; 176(10): 5950-7.
21. He H, Yang P, Jiang L, et al. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation. BMC Immunol 2008; 9: 53.
22. Chattopadhyay S, O'Rourke J, Cone RE. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Int Immunol 2008; 20(4): 509-16.
23. D'Orazio TJ, Mayhew E, Niederkorn JY. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol 2001; 166(1): 26-32.
24. Streilein JW, Masli S, Takeuchi M, Kezuka T. The eye's view of antigen presentation. Hum Immunol 2002; 63(6): 435-43.
25. Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci 1996; 37(13): 2700-7.
26. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 1993; 150(5): 1727-34.
27. Mizuno K, Clark AF, Streilein JW. Anterior chamberassociated immune deviation induced by soluble antigens. Invest Ophthalmol Vis Sci 1989; 30(6): 1112-9.
28. Sonoda KH, Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT celldependent tolerance. Eur J Immunol 2002; 32(3): 848-57.
29. She SC, Steahly LP, Moticka EJ. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci 1990; 31(10): 1950-6.
30. Pietrini F, Iori V, Cheremisina A, et al. Evaluation of nickel tolerance in Amaranthus paniculatus L. plants by measuring photosynthesis, oxidative status, antioxidative response and metal-binding molecule content. Environ Sci Pollut Res Int 2014; [Epub ahead of print].
31. Jensen CS, Lisby S, Baadsgaard O, Byrialsen K, Menne T. Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individuals. Contact Dermatitis 2003; 48(6): 300-4.
32. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003; 171(11): 5760-8.
33. Nowak M, Kopp F, Roelofs-Haarhuis K, Wu X, Gleichmann E. Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells. J Immunol 2006; 176(8): 4581-9.
34. Artik S, Haarhuis K, Wu X, Begerow J, Gleichmann E. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J Immunol 2001; 167(12): 6794-803.
35. Ishii N, Moriguchi N, Nakajima H, Tanaka S, Amemiya F. Nickel sulfate-specific suppressor T cells induced by nickel sulfate in drinking water. J Dermatol Sci 1993; 6(2): 159-64.
36. Roelofs-Haarhuis K, Wu X, Gleichmann E. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 2004; 173(2): 1043-50.
37. D'Orazio TJ, Niederkorn JY. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response. Eur J Immunol 1998; 28(5): 1544-53.
38. Streilein JW, Okamoto S, Hara Y, Kosiewicz M, Ksander B. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen. Invest Ophthalmol Vis Sci 1997; 38(11): 2245-54.
39. Ferguson TA, Herndon JM. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest Ophthalmol Vis Sci 1994; 35(7): 3085-93.
40. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol 1992; 39(3): 185-200.
41. Faunce DE, Sonoda KH, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166(1): 313-21.
42. Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169(1): 31-8.
43. Roelofs-Haarhuis K, Wu X, Nowak M, Fang M, Artik S, Gleichmann E. Infectious nickel tolerance: a reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. J Immunol 2003; 171(6): 2863-72.
44. Niederkorn JY, Mayhew E. Role of splenic B cells in the immune privilege of the anterior chamber of the eye. Eur J Immunol 1995; 25(10): 2783-7.
45. Faunce DE, Sonoda KH, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166(1): 313-21.
46. Farooq SM, Kumar A, Ashour HM. Eye-mediated immune tolerance to Type II collagen in arthritis-prone strains of mice. J Cell Mol Med 2014; 18(12): 2512-8.
47. Czarnobilska E, Obtulowicz K, Wsolek K, Pietowska J, Spiewak R. [Mechanisms of nickel allergy]. Przeglad lekarski 2007; 64(7-8): 502-5.
48. Ricciardi L, Carni A, Loschiavo G, et al. Systemic nickel allergy: oral desensitization and possible role of cytokines interleukins 2 and 10. Int J Immunopathol Pharmacol 2013; 26(1): 251-7.
49. Niederkorn JY. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation. Transplantation 1987; 43(4): 523-8.
50. Li XY, D'Orazio LT, Niederkorn JY. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 1996; 89(1): 34-40.
51. Fujimoto M, Ukichi K, Okamura T, et al. Splenocyte cytokine profile in mouse with oral mucosa-sensitization and oraltolerization by NiSO(4). Bull Tokyo Dental Coll 2011; 52(2): 85-93.
52. Ashour HM, Niederkorn JY. Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye. Int Arch Allergy Immunol 2007; 144(4): 343-6.
53. Kosiewicz MM, Alard P, Streilein JW. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGFbeta and IL-4 production. J Immunol 1998; 161(10): 5382-90.